Drug Substance (CDMO/CRO)
Drug Product (CMO)

Find and compare companies providing:
Contract pharmaceutical outsourcing services


Filter by expertise, certification, scale and geography to shortlist trusted contract pharmaceutical service providers for effective pharma outsourcing.

HIGHLIGHTED

Located in:

India

Plants in:

India

Established in: 1998

Production scale:

small

medium

large

Employees: 1000

Facilities with global regulatory compliance

Customized and Flexible Collaboration Models

End-to-end drug discovery

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

  • ema

Replies quickly

HIGHLIGHTED

Located in:

India

Plants in:

India

Established in: 2023

Production scale:

small

medium

large

Employees: 1000+

Expertise in Conventional, Complex, and Niche Chemistries

End-to-end Support from early development to Commercial Phases

Comprehensive Analytical Support Facilities

  • GMP

  • FDA

  • EMA

All certificates

  • fda

  • ema

  • gmp

Replies quickly

HIGHLIGHTED

Located in:

United States

CDMO-CMO


Plants in:

GermanyFranceGreeceSwitzerlandNorwayJapan

Production scale:

large

medium

small

Specialized in complex product development and manufacturing.

High-quality standards with a focus on customer-specific needs.

Agile and innovative approach to CDMO services.

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

  • ema

Replies quickly

HIGHLIGHTED

Located in:

Germany

Plants in:

Germany

Established in: 2008

Production scale:

large

small

medium

Employees: 4.000

With 14 production sites in Europe and the USA

7 Development Centers of Excellence covering all dosage forms

13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

  • ema

Replies quickly

Plants in:

China

Established in: 1987

Production scale:

medium

small

large

Employees: 50+

ISO 9001:2015 & SGS audited supplier

One-stop CDMO Solutions for APl and Key intermediates

Specialized in APIs & Pharmaceutical Intermediates for 38 years

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

Replies quickly

Plants in:

India

Established in: 1989

Production scale:

large

Employees: 5000+

6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

R&D Centers with capabilities of ANDAs, DMFs and NDDS

462+ patents filed for drug substances and polymorphs

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

Replies quickly

CDMO-CMO


Plants in:

Poland

Established in: 1951

Production scale:

medium

Employees: 455+

Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.

FDA approved european manufcaturing facilities

Export APIs to more than 60 countries worldwide

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

Replies quickly

CDMO-CMO


Plants in:

United StatesIndiaFranceGermanyUnited KingdomSpainItaly

Established in: 1991

Production scale:

small

medium

large

Employees: 3,500+

More than 12 GMP manufacturing facilities (EU, US, India)

Portfolio of more than 240 commercial APIs

We are experts in the cGMP production of highly potent compounds

  • GMP

  • FDA

  • EMA

All certificates

    Replies quickly

    Located in:

    United States

    Plants in:

    China

    Established in: 2006

    Production scale:

    small

    medium

    large

    Employees: 3500

    Silver EcoVadis awardee committed to sustainability

    Exceptional synthesis experience of HPAPIs

    One-stop CDMO Solutions for APl and Key intermediates

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    Replies quickly

    Plants in:

    Germany

    Established in: 1980

    Production scale:

    medium

    Employees: 30+

    EU-GMP and DIN EN ISO 9001:2015

    Pioneer in the fractionation of sheep plasma

    Pure & sterile high-quality products

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Located in:

    Belgium

    CDMO-CMO


    Plants in:

    Belgium

    Established in: 2018

    Production scale:

    large

    Comprehensive drug development services from molecule to market.

    Expertise in nanomedicine and drug repurposing.

    Tailored project management ensuring efficiency and transparency.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    United States

    Plants in:

    United States

    Established in: 2002

    Production scale:

    large

    Specialized in biologics CDMO services with a focus on monoclonal antibodies.

    Advanced facilities for clinical and commercial-scale manufacturing.

    Strong commitment to quality and regulatory compliance.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    Replies slower than most

    Located in:

    Norway

    CDMO-CMO


    Plants in:

    Norway

    Established in: 2007

    Production scale:

    small

    large

    Specialized in liquid and semi-solid pharmaceuticals manufacturing.

    Nordic excellence in quality and reliability.

    Flexible production capabilities catering to a wide range of batch sizes.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    United States

    CDMO-CMO


    Plants in:

    United States

    Established in: 1933

    Production scale:

    large

    Pioneering in advanced delivery technologies and development solutions.

    Extensive global network ensuring supply chain resilience.

    Tailored services across biologics, gene therapies, and pharmaceuticals.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    Germany

    Plants in:

    Germany

    Established in: 1885

    Production scale:

    large

    Strong heritage in pharmaceutical innovation and biotechnology.

    Comprehensive range of services from early development to commercial supply.

    Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    Germany

    CDMO-CMO


    Plants in:

    Germany

    Established in: 2009

    Production scale:

    large

    Specialized in enzyme-based products and custom biocatalysis solutions.

    Strong focus on sustainability and green chemistry in pharmaceutical manufacturing.

    Innovative R&D for novel enzyme applications and process optimization.

    • GMP

    • FDA

    • EMA

    All certificates

      Replies slower than most

      Located in:

      United States

      Plants in:

      United States

      Established in: 1996

      Production scale:

      large

      small

      medium

      Leading in biopharmaceutical development and biologic API production.

      Comprehensive services from cell line development to commercial manufacturing.

      Strong track record in delivering complex and high-quality biologics.

      • GMP

      • FDA

      • EMA

      All certificates

      • gmp

      • ema

      • fda

      Replies quickly

      Biologics

      Biologics are therapeutic products derived from living organisms. CDMOs in this space support cell culture, protein expression, purification, and GMP production of biologic drug substances and products.

      What Are Contract Pharma Services?

      Contract pharma services—also called pharma outsourcing services or pharmaceutical outsourcing—refer to hiring specialised external organisations to handle key stages of drug discovery, development and manufacturing. These partners (CDMOs, CMOs, CROs and other niche providers) supply the GMP infrastructure, technical expertise and regulatory know-how that allow innovators to move molecules from lab bench to commercial product without the heavy capex of building their own facilities.


      Why Outsource? Top Advantages

      • Accelerated Timelines: Tap into pre-validated processes and qualified plants to shave months off development and scale-up.
      • Capital Efficiency: Convert fixed overhead into variable expenditure—pay only for the capacity you use.
      • Regulatory Peace of Mind: Work with partners that hold FDA, EMA, MHRA, WHO-GMP, ISO and other global certifications.
      • Access to Cutting-Edge Tech: High-potency suites, continuous manufacturing, aseptic isolators, nano-milling—available without multi-million-euro investments.

      Choose Your Service Chapter

      Before you explore provider profiles, decide which chapter of the pharmaceutical value chain you need help with:


      1. Drug Substance (CDMO / CRO)

      The drug substance—also known as the active pharmaceutical ingredient (API)—is the therapeutic core of every medicine.


      Typical services include:

      • Route scouting & process chemistry
      • cGMP API manufacturing (small-, mid- and large-scale)
      • Highly potent & controlled-substance handling
      • Analytical method development & validation
      • Tech transfer and scale-up support

      Ideal partners: CDMOs and CROs experienced in synthetic or biologic API production, with proven regulatory track records.


      2. Drug Products (Manufactured by CMOs)

      Once your API is ready, it must be formulated into a drug product that patients can safely administer.


      Typical services include:

      • Formulation & process development (oral, parenteral, topical, inhalation, etc.)
      • Sterile fill-finish and lyophilisation
      • Tableting, capsule filling, sachet & stick-pack filling
      • Primary & secondary packaging, labelling and serialisation
      • Stability studies and ICH-compliant storage

      Ideal partners: CMOs with dosage-form expertise, modern fill-finish lines, and robust quality-management systems.


      How to Use This Directory

      1. Define your Project Needs: Click Drug Substance or Drug Products above to narrow results to the services you need.
      2. Refine with Filters: Apply filters—capacity range, certifications, geography—to shortlist partners.
      3. Compare Profiles: Review facility photos, batch-size capabilities, QMS details and audit history.
      4. Request Quotes Instantly: Send RFQs to multiple providers via Pharmaoffer’s secure messaging—no hidden mark-ups or broker fees.

      Quality & Regulatory Considerations


    • Regulatory Track Record: Demonstrates consistent GMP compliance and successful authority inspections.
    • Technical Fit: Specialised equipment (HPAPI isolators, lyophilisers, sterile suites) aligned with your molecule’s needs.
    • Scalability: Ability to move from pilot batches to commercial volumes without changing sites.
    • Supply-Chain Resilience: Multisite redundancy and geographic spread to mitigate disruptions.
    • Quality Culture: Strong QMS, data-integrity controls and transparent deviation management.


    • Frequently Asked Questions

      What’s the difference between a CDMO and a CMO?

      All CDMOs are CMOs, but CDMOs also provide development services—route optimisation, formulation R&D—while CMOs focus solely on manufacturing.

      How do I verify a partner’s GMP status?

      Each profile contains downloadable certificates (FDA, EMA, WHO, ISO). You can also request the latest audit reports directly.

      Can early-stage biotechs afford outsourcing?

      Yes. Outsourcing gives small teams access to world-class facilities without upfront investment; you pay for the batches you need.

      What information is required for an accurate quote?

      Molecule details, dosage form, batch size, projected volumes, timelines, and any special handling requirements (e.g., cytotoxic, cold-chain, controlled substances).

      Do providers offer end-to-end support?

      Some partners cover both Drug Substance and Drug Product; others specialise. Start with the chapter you need and explore integrated options.


      Ready to Accelerate Your Project?

      Choose Drug Substance or Drug Products and connect with GMP-certified experts to move your molecule forward—faster, safer and more cost-effectively.